A groundbreaking research project worth one million pounds at the University of Sheffield is set to explore the survival strategies of abnormal cells that defy odds by enduring chromosomal imbalances.
Directed by Professor Ivana Barbaric and in collaboration with Barts Cancer’s Professor Sarah McClelland, the study seeks to decipher why certain cells withstand, and even exploit, aneuploidy—a chromosomal abnormality often fatal or malfunction-inducing in ordinary cells.
This pivotal research aims to expose molecular pathways that enhance our understanding and treatment of cancer, while also promising advancements in regenerative medicine and fertility therapy through stabilized stem cell applications.
(With inputs from agencies.)